Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in Japan

Factor XIII (FXIII) deficiency is a rare but serious coagulopathy. FXIII is critical in blood coagulation, and FXIII deficiencies can lead to uncontrolled or spontaneous bleeding. FXIII deficiencies can be congenital or acquired; acquired FXIII deficiency can be categorized as autoimmune and non-aut...

Full description

Bibliographic Details
Main Authors: Shiho Amano, Kohei Oka, Yutaka Sato, Chiaki Sano, Ryuichi Ohta
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/6/1699
_version_ 1797470442775117824
author Shiho Amano
Kohei Oka
Yutaka Sato
Chiaki Sano
Ryuichi Ohta
author_facet Shiho Amano
Kohei Oka
Yutaka Sato
Chiaki Sano
Ryuichi Ohta
author_sort Shiho Amano
collection DOAJ
description Factor XIII (FXIII) deficiency is a rare but serious coagulopathy. FXIII is critical in blood coagulation, and FXIII deficiencies can lead to uncontrolled or spontaneous bleeding. FXIII deficiencies can be congenital or acquired; acquired FXIII deficiency can be categorized as autoimmune and non-autoimmune. Immunological tests to measure FXIII inhibitors are required to diagnose acquired FXIII deficiency; however, appropriate test facilities are limited, which increases the turnaround time of these tests. In the case of critical bleeding, delayed test results may worsen prognosis due to delayed treatment. Here, we report a case of acquired FXIII deficiency, followed by a review of FXIII deficiency cases in Japan. We performed a systematic review to investigate the present conditions of the diagnosis and treatment of FXIII deficiency, including the measurement of FXIII inhibitors in Japan. FXIII inhibitor testing was only performed in 29.7 of acquired FXIII deficiency cases. Clinical departments other than internal medicine and pediatrics were often involved in medical treatment at the time of onset. Therefore, it is important for doctors in clinical departments other than internal medicine and pediatrics to consider FXIII deficiency and perform FXIII inhibitor testing when examining patients with prolonged bleeding of unknown cause or persistent bleeding after trauma.
first_indexed 2024-03-09T19:36:24Z
format Article
id doaj.art-38948ddebefb4f1d9ba3f9f8e84e1ba6
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T19:36:24Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-38948ddebefb4f1d9ba3f9f8e84e1ba62023-11-24T01:51:06ZengMDPI AGJournal of Clinical Medicine2077-03832022-03-01116169910.3390/jcm11061699Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in JapanShiho Amano0Kohei Oka1Yutaka Sato2Chiaki Sano3Ryuichi Ohta4Community Care, Unnan City Hospital, Unnan 699-1221, JapanMedical Department, Shimane University, 89-1 Enya cho, Izumo 693-8501, JapanMedical Department, Shimane University, 89-1 Enya cho, Izumo 693-8501, JapanDepartment of Community Medicine Management, Faculty of Medicine, Shimane University, Izumo 693-8501, JapanCommunity Care, Unnan City Hospital, Unnan 699-1221, JapanFactor XIII (FXIII) deficiency is a rare but serious coagulopathy. FXIII is critical in blood coagulation, and FXIII deficiencies can lead to uncontrolled or spontaneous bleeding. FXIII deficiencies can be congenital or acquired; acquired FXIII deficiency can be categorized as autoimmune and non-autoimmune. Immunological tests to measure FXIII inhibitors are required to diagnose acquired FXIII deficiency; however, appropriate test facilities are limited, which increases the turnaround time of these tests. In the case of critical bleeding, delayed test results may worsen prognosis due to delayed treatment. Here, we report a case of acquired FXIII deficiency, followed by a review of FXIII deficiency cases in Japan. We performed a systematic review to investigate the present conditions of the diagnosis and treatment of FXIII deficiency, including the measurement of FXIII inhibitors in Japan. FXIII inhibitor testing was only performed in 29.7 of acquired FXIII deficiency cases. Clinical departments other than internal medicine and pediatrics were often involved in medical treatment at the time of onset. Therefore, it is important for doctors in clinical departments other than internal medicine and pediatrics to consider FXIII deficiency and perform FXIII inhibitor testing when examining patients with prolonged bleeding of unknown cause or persistent bleeding after trauma.https://www.mdpi.com/2077-0383/11/6/1699factor XIII deficiencybleeding disorderfactor XIII inhibitorsacquired factor XIII deficiency
spellingShingle Shiho Amano
Kohei Oka
Yutaka Sato
Chiaki Sano
Ryuichi Ohta
Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in Japan
Journal of Clinical Medicine
factor XIII deficiency
bleeding disorder
factor XIII inhibitors
acquired factor XIII deficiency
title Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in Japan
title_full Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in Japan
title_fullStr Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in Japan
title_full_unstemmed Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in Japan
title_short Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in Japan
title_sort measuring factor xiii inhibitors in patients with factor xiii deficiency a case report and systematic review of current practices in japan
topic factor XIII deficiency
bleeding disorder
factor XIII inhibitors
acquired factor XIII deficiency
url https://www.mdpi.com/2077-0383/11/6/1699
work_keys_str_mv AT shihoamano measuringfactorxiiiinhibitorsinpatientswithfactorxiiideficiencyacasereportandsystematicreviewofcurrentpracticesinjapan
AT koheioka measuringfactorxiiiinhibitorsinpatientswithfactorxiiideficiencyacasereportandsystematicreviewofcurrentpracticesinjapan
AT yutakasato measuringfactorxiiiinhibitorsinpatientswithfactorxiiideficiencyacasereportandsystematicreviewofcurrentpracticesinjapan
AT chiakisano measuringfactorxiiiinhibitorsinpatientswithfactorxiiideficiencyacasereportandsystematicreviewofcurrentpracticesinjapan
AT ryuichiohta measuringfactorxiiiinhibitorsinpatientswithfactorxiiideficiencyacasereportandsystematicreviewofcurrentpracticesinjapan